鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/11/12 | 2,812 | 2,826 | 2,801 | 2,812 | +31 | +1.1% | 69,400 |
2019/11/11 | 2,787 | 2,787 | 2,751 | 2,781 | +22 | +0.8% | 24,400 |
2019/11/08 | 2,811 | 2,812 | 2,741 | 2,759 | -28 | -1% | 48,400 |
2019/11/07 | 2,774 | 2,796 | 2,760 | 2,787 | +21 | +0.8% | 47,000 |
2019/11/06 | 2,796 | 2,796 | 2,762 | 2,766 | -34 | -1.2% | 38,100 |
2019/11/05 | 2,801 | 2,877 | 2,789 | 2,800 | -5 | -0.2% | 85,500 |
2019/11/01 | 2,800 | 2,846 | 2,790 | 2,805 | -85 | -2.9% | 91,100 |
2019/10/31 | 2,947 | 2,947 | 2,871 | 2,890 | -60 | -2% | 54,100 |
2019/10/30 | 2,867 | 2,952 | 2,835 | 2,950 | +107 | +3.8% | 120,500 |
2019/10/29 | 2,835 | 2,867 | 2,811 | 2,843 | +25 | +0.9% | 62,900 |
2019/10/28 | 2,826 | 2,832 | 2,813 | 2,818 | +7 | +0.2% | 48,900 |
2019/10/25 | 2,836 | 2,836 | 2,796 | 2,811 | -3 | -0.1% | 52,200 |
2019/10/24 | 2,827 | 2,830 | 2,803 | 2,814 | +3 | +0.1% | 45,400 |
2019/10/23 | 2,781 | 2,818 | 2,769 | 2,811 | +27 | +1% | 93,700 |
2019/10/21 | 2,800 | 2,800 | 2,774 | 2,784 | -27 | -1% | 38,500 |
2019/10/18 | 2,791 | 2,854 | 2,791 | 2,811 | +20 | +0.7% | 70,400 |
2019/10/17 | 2,795 | 2,801 | 2,777 | 2,791 | +1 | ±0% | 53,600 |
2019/10/16 | 2,800 | 2,806 | 2,778 | 2,790 | +18 | +0.6% | 65,900 |
2019/10/15 | 2,796 | 2,796 | 2,751 | 2,772 | +24 | +0.9% | 80,700 |
2019/10/11 | 2,741 | 2,756 | 2,706 | 2,748 | -2 | -0.1% | 56,200 |
2019/10/10 | 2,780 | 2,791 | 2,740 | 2,750 | -32 | -1.2% | 93,600 |
2019/10/09 | 2,807 | 2,812 | 2,768 | 2,782 | -38 | -1.3% | 49,500 |
2019/10/08 | 2,800 | 2,820 | 2,786 | 2,820 | +18 | +0.6% | 69,500 |
2019/10/07 | 2,805 | 2,812 | 2,784 | 2,802 | +17 | +0.6% | 48,900 |
2019/10/04 | 2,784 | 2,810 | 2,746 | 2,785 | -10 | -0.4% | 105,900 |
2019/10/03 | 2,828 | 2,828 | 2,782 | 2,795 | -75 | -2.6% | 66,000 |
2019/10/02 | 2,873 | 2,912 | 2,860 | 2,870 | -37 | -1.3% | 43,200 |
2019/10/01 | 2,871 | 2,911 | 2,870 | 2,907 | +22 | +0.8% | 43,300 |
2019/09/30 | 2,838 | 2,890 | 2,838 | 2,885 | +3 | +0.1% | 40,400 |
2019/09/27 | 2,931 | 2,931 | 2,847 | 2,882 | -56 | -1.9% | 48,500 |
2019/09/26 | 3,005 | 3,010 | 2,930 | 2,938 | -82 | -2.7% | 74,100 |
2019/09/25 | 2,988 | 3,035 | 2,971 | 3,020 | +30 | +1% | 55,500 |
2019/09/24 | 2,993 | 3,005 | 2,976 | 2,990 | -20 | -0.7% | 103,600 |
2019/09/20 | 2,917 | 3,025 | 2,916 | 3,010 | +93 | +3.2% | 212,700 |
2019/09/19 | 2,860 | 2,918 | 2,821 | 2,917 | +70 | +2.5% | 154,700 |
2019/09/18 | 2,900 | 2,900 | 2,821 | 2,847 | -53 | -1.8% | 115,700 |
2019/09/17 | 2,852 | 2,920 | 2,812 | 2,900 | +82 | +2.9% | 111,800 |
2019/09/13 | 2,813 | 2,830 | 2,797 | 2,818 | +32 | +1.1% | 110,600 |
2019/09/12 | 2,837 | 2,837 | 2,782 | 2,786 | -30 | -1.1% | 54,100 |
2019/09/11 | 2,800 | 2,823 | 2,791 | 2,816 | +16 | +0.6% | 51,900 |
2019/09/10 | 2,829 | 2,836 | 2,780 | 2,800 | -40 | -1.4% | 73,000 |
2019/09/09 | 2,816 | 2,840 | 2,795 | 2,840 | +24 | +0.9% | 97,600 |
2019/09/06 | 2,792 | 2,856 | 2,774 | 2,816 | -2 | -0.1% | 53,700 |
2019/09/05 | 2,830 | 2,852 | 2,796 | 2,818 | +2 | +0.1% | 100,700 |
2019/09/04 | 2,808 | 2,877 | 2,798 | 2,816 | +5 | +0.2% | 99,900 |
2019/09/03 | 2,800 | 2,835 | 2,794 | 2,811 | +43 | +1.6% | 96,300 |
2019/09/02 | 2,672 | 2,798 | 2,670 | 2,768 | +103 | +3.9% | 88,400 |
2019/08/30 | 2,679 | 2,679 | 2,647 | 2,665 | +9 | +0.3% | 40,300 |
2019/08/29 | 2,700 | 2,700 | 2,646 | 2,656 | ±0 | ±0% | 24,600 |
2019/08/28 | 2,577 | 2,660 | 2,567 | 2,656 | +86 | +3.3% | 68,600 |
1351~
1400
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム